NEW HAVEN, Conn. (WTNH) — Hartford HealthCare’s March VADness is here – a slam dunk in heart care innovation! Join us as we ...
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced financial ...
BrioHealth Solutions ( today announces the successful implantation of its 100th BrioVAD System, an investigational ...
GlobalData on MSN
BIOTRONIK begins trial of LivIQ pacemaker system
The prospective multi-centre BIO-LivIQ trial will enrol 325 patients across 60 sites worldwide.
German Hospitals Now Eligible to Negotiate Full Coverage for Revivent Therapy Our team has successfully secured full ...
Conduction system pacing was found to be inferior to biventricular pacing for key outcomes in HFrEF with left bundle-branch ...
Medtronic snagged FDA approval for an expanded indication for its OmniaSecure defibrillation lead. Check out why this tiny ...
Two multicenter trials drew different conclusions about the value of conduction system relative to biventricular pacing for ...
The OmniaSecure lead gained the first U.S. approval for placement in the heart’s left bundle branch area, to help activate ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Medtronic announced today that it received FDA approval for an expanded indication for its OmniaSecure defibrillation lead.
Turco, an interventional cardiologist, has held roles including CEO of JC Medical and chief medical officer of Medtronic’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results